Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer
Pezaro CJ, Omlin A, Mastris K, ANZUP Consumer Advisory Panel, Attard G, Beer TM, Chi KN, Chowdhury S, Davis ID, Drake CG, de Bono JS, Efstathiou E, Gravis G, Higano CS..., Ann Oncol, 1/1/2017Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
Kanz BA, Pollack MH, Johnpulle RA, Puzanov I, Horn L, Morgans AK, Sosman JA, Rapisuwon S, Conry RM, Eroglu Z, Johnson DB, Journal for ImmunoTherapy of Cancer, 1/1/2016Optimal management of muscle-invasive bladder cancer - a review
Scarpato KR, Morgans AK, Moses KA, Res Rep Urol, 1/1/2015
